8
Views
59
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Regulation of Differentiation by HBP1, a Target of the Retinoblastoma Protein

, &
Pages 4732-4743 | Published online: 27 Mar 2023

REFERENCES

  • Barone, M. V., A. Crozat, A. Tabaee, L. Philipson, and D. Ron 1994. CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest. Genes Dev. 8: 453–464.
  • Batchvarova, N., X. Z. Wang, and D. Ron 1995. Inhibition of adipogenesis by the stress-induced protein CHOP (Gadd153). EMBO J. 14: 4654–4661.
  • Braun, T., M. Rudnicki, H.-H. Arnold, and R. Jaenisch 1992. Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death. Cell 71: 369–382.
  • Chen, P. L., D. J. Riley, Y. Chen, and W. H. Lee 1996. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev. 10: 2794–2804.
  • Cheng, T. C., B. S. Tseng, J. P. Merlie, W. H. Klein, and E. N. Olson 1995. Activation of the myogenin promoter during mouse embryogenesis in the absence of positive autoregulation. Proc. Natl. Acad. Sci. USA 92: 561–565.
  • Classon, M., C. Gorka, B. K. Kennedy, N. Dyson, and E. Harlow. Opposing roles for pRB and p107/p130 in adipocyte differentiation. Submitted for publication.
  • Cobrinik, D., P. Whyte, D. Peeper, T. Jacks, and R. Weinberg 1993. Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev. 7: 2392–2404.
  • Corbeil, H., P. Whyte, and P. E. Branton 1995. Characterization of transcription factor E2F complexes during muscle and neuronal differentiation. Oncogene 11: 909–920.
  • Cress, W. D., and J. R. Nevins Use of the E2F transcription factor by DNA tumor virus regulatory proteins Transcriptional control of cell growth: the E2F gene family In: Farnham, P. J.208199663–78Springer-Verlag, New York, N.Y.
  • Datta, B., W. Min, S. Burma, and P. Lengyel 1998. Increase in p202 expression during skeletal muscle differentiation: inhibition of MyoD protein expression and activity of p202. Mol. Cell. Biol. 18: 1074–1083.
  • Farnham, P. J. 1996. Transcriptional control of cell growth: the E2F family 208 Springer-Verlag, New York, N.Y.
  • Fiddler, T. A., L. Smith, S. J. Tapscott, and M. J. Thayer 1996. Amplification of MDM2 inhibits MyoD-mediated myogenesis. Mol. Cell. Biol. 16: 5048–5057.
  • Grosschedl, R. 1995. Higher order nucleoprotein complexes in transcription: analogies with site-specific recombination. Curr. Opin. Cell Biol. 7: 362–370.
  • Gu, W., J. W. Schneider, G. Condorelli, S. Kaushal, V. Mahdavi, and B. Nadal-Ginard 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72: 309–324.
  • Hunter, T. 1997. Oncoprotein networks. Cell 88: 333–346.
  • Hurford, R. K., D. Cobrinik, M.-H. Lee, and N. Dyson 1997. pRb and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev. 11: 1447–1463.
  • Ikeda, M. A., L. Jakoi, and J. R. Nevins 1996. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. USA 93: 3215–3220.
  • Lassar, A., M. Thayer, R. Overell, and H. Weintraub 1989. Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1. Cell 58: 659–667.
  • Lavender, P., L. Vandel, A. J. Bannister, and T. Kouzarides 1997. The HMG-box transcription factor HBP1 is targeted by the pocket proteins and E1A. Oncogene 14: 2721–2728.
  • Lazaro, J. B., M. Kitzmann, M. A. Poul, M. Vandromme, N. J. Lamb, and A. Fernandez 1997. Cyclin dependent kinase 5, cdk5, is a positive regulator of myogenesis in mouse C2 cells. J. Cell Sci. 110: 1251–1260.
  • Lesage, F., J. P. Hugnot, E. Z. Amri, P. Grimaldi, J. Barhanin, and M. Lazdunski 1994. Expression cloning in the K+ transport-defective yeast and regulation of HBP1, a new putative HMG transcriptional regulator. Nucleic Acids Res. 22: 3685–3688.
  • Maione, R., and P. Amati 1997. Interdependence between muscle differentiation and cell-cycle control. Biochim. Biophys. Acta 1332: M19–M30.
  • Maione, R., G. Fimia, P. Holman, B. Schaffhausen, and P. Amati 1994. Retinoblastoma antioncogene is involved in the inhibition of myogenesis by polyomavirus large T antigen. Cell Growth Differ. 5: 231–237.
  • Maroto, M., R. Reshef, E. Munsterberger, S. Koester, M. Goulding, and A. B. Lassar 1997. Ectopic Pax-3 activates MyoD and Myf-5 expression in embryonic mesoderm and neural tissue. Cell 89: 139–148.
  • Moberg, K., M. A. Starz, and J. A. Lees 1996. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol. Cell. Biol. 16: 1436–1449.
  • Molkentin, J. D., and E. N. Olson 1996. Defining the regulatory networks for muscle development. Curr. Opin. Genet. Dev. 6: 445–453.
  • Molkentin, J. D., and E. N. Olson 1996. Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc. Natl. Acad. Sci. USA 93: 9366–9373.
  • Mulligan, G. J., J. Wong, and T. Jacks 1998. p130 is dispensable in peripheral T lymphocytes: evidence for functional compensation by p107 and pRB. Mol. Cell. Biol. 18: 206–220.
  • Murre, C., P. S. McCaw, H. Vaessin, M. Caudy, L. Y. Jan, Y. N. Jan, C. V. Cabrera, J. N. Buskin, S. D. Hauschka, A. B. Lassar, H. Weintraub, and D. Baltimore 1989. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58: 537–544.
  • Novitch, B. G., G. J. Mulligan, T. Jacks, and A. B. Lassar 1996. Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle. J. Cell Biol. 135: 441–456.
  • Nusse, R. 1997. A versatile transcriptional effector of wingless signaling. Cell 89: 321–323.
  • Olson, E. N., and W. H. Klein 1994. bHLH factors in muscle development: deadlines and commitments, what to leave in and what to leave out. Genes Dev. 8: 1–8.
  • Olson, E. N., G. Spizz, and M. Tainsky 1987. The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation. Mol. Cell. Biol. 7: 2104–2111.
  • Phillipot, A., E. Porro, M. W. Kirschner, and L.-H. Tsai 1997. The role of cyclin-dependent kinase 5 and a novel regulatory subunit in regulating muscle differentiation and patterning. Genes Dev. 11: 1409–1421.
  • Rao, S., C. Chu, and S. Kohtz 1994. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix proteins. Mol. Cell. Biol. 14: 5259–5267.
  • Rawls, A., and E. N. Olson 1997. MyoD meets its maker. Cell 89: 5–8.
  • Riley, D. J., C. Y. Liu, and W. H. Lee 1997. Mutations of N-terminal regions render the retinoblastoma protein insufficient for functions in development and tumor suppression. Mol. Cell. Biol. 17: 7342–7352.
  • Ron, D., and J. F. Habener 1992. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev. 6: 439–453.
  • Rudnicki, M., T. Braun, S. Hinuma, and R. Jaenisch 1992. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell 71: 383–390.
  • Rudnicki, M., T. Braun, S. Hinuma, and R. Jaenisch 1993. MyoD or Myf 5 is required for formation of skeletal muscle. Cell 75: 1351–1359.
  • Schneider, J. W., W. Gu, L. Zhu, V. Mahdavi, and B. Nadal-Ginard 1994. Reversal of terminal differentiation mediated by p107 in Rb−/− muscle cells. Science 264: 1467–1470.
  • Sellers, W. R., B. G. Novitch, S. Miyake, A. Heith, G. A. Otterson, F. J. Kaye, A. B. Lassar, and W. G. J. Kaelin 1998. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev. 12: 95–106.
  • Sheppard, K. A., and A. S. Yee. Unpublished observations.
  • Shin, E., A. Shin, C. Paulding, B. Schaffhausen, and A. S. Yee 1995. Multiple changes in E2F transcription factor function occur upon muscle differentiation. Mol. Cell. Biol. 15: 2252–2262.
  • Skapek, S. X., J. Rhee, D. B. Spicer, and A. B. Lassar 1995. Inhibition of myogenic differentiation in proliferating myoblast by cyclin D1-dependent kinase. Science 267: 1022–1023.
  • Smith, E. J., G. Leone, J. DeGregori, L. Jakoi, and J. R. Nevins 1996. The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state. Mol. Cell. Biol. 16: 6965–6976.
  • Sternberg, E. A., G. Spizz, M. W. Perry, D. Vizard, T. Weil, and E. N. Olson 1988. Identification of upstream and intragenic regulatory elements that confer cell type-restricted and differentiation-specific expression on the muscle creatine kinase gene. Mol. Cell. Biol. 8: 2896–2909.
  • Tajbakhsh, S., D. Rocancourt, G. Cossu, and M. Buckingham 1997. Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD. Cell 89: 127–138.
  • Tevosian, S. Unpublished data.
  • Tevosian, S., K. E. Paulson, R. Bronson, and A. S. Yee 1996. Expression of the E2F-1/DP-1 transcription factor during murine development. Cell Growth Differ. 7: 43–52.
  • Tevosian, S. G., H. Shih, K. G. Mendelson, K. A. Sheppard, K. E. Paulson, and A. S. Yee 1997. HBP1: an HMG box transcriptional repressor that is targeted by the retinoblastoma family. Genes Dev. 11: 383–396.
  • Thayer, M. J., S. J. Tapscott, R. L. Davis, W. Wright, A. B. Lassar, and H. Weintraub 1989. Positive auto-regulation of the myogenic determination gene MyoD1. Cell 58: 241–248.
  • Weintraub, H., R. Davis, D. Lockshon, and A. Lassar 1990. MyoD binds cooperatively to two sites in a target enhancer sequence: occupancy of two sites is required for activation. Proc. Natl. Acad. Sci. USA 87: 5623–5627.
  • Yee, A. S., P. Raychaudhuri, L. Jakoi, and J. R. Nevins 1989. The adenovirus-inducible factor E2F stimulates transcription following specific DNA binding. Mol. Cell. Biol. 9: 578–585.
  • Yee, A. S., H. S. Shih, and S. G. Tevosian 1998. New perspectives on retinoblastoma family functions in differentiation. Front. Biosci., in press.
  • Yee, S. P., and P. W. Rigby 1993. The regulation of myogenin gene expression during the embryonic development of the mouse. Genes Dev. 7: 1277–1289.
  • Yeh, W. C., Z. Cao, M. Classon, and S. L. McKnight 1995. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev. 9: 168–181.
  • Zackenhaus, E., Z. Jiang, D. Chung, J. D. Marth, R. A. Phillips, and B. L. Gallie 1996. pRB controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev. 10: 3051–3064.
  • Zingg, J. M., G. Pedrazza-Alva, and J. P. Jost 1994. MyoD1 promoter autoregulation is mediated by two proximal E-boxes. Nucleic Acids Res. 22: 2234–2241.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.